Patients Stopping Weight-Loss Injections Gain Back Weight Far More Rapidly Than People Using Diet and Exercise

A recent study suggests that patients who stop using new weight-loss injections like Mounjaro or Wegovy tend to recover lost weight much more quickly than those who stop conventional diet and exercise regimens.

Research printed in a major health publication points out that while obese people can lose a large proportion of their total mass while on the medication, the mass returns at an estimated rate of nearly a kilo each month after stopping.

"Individuals buying these treatments must be informed of the risk of fast rebound weight gain when the treatment is stopped," stated researcher Dr. Susan Jebb.

Such speed of recovery means a reversion to original weight in about a year and a half.

Analyzing Treatments

The analysis, which examined dozens of trials involving over 9,000 of participants, contrasted the results of the injectable medications with other pills.

The team note that people who shed pounds through lifestyle changes alone usually have a slower weight regain—perhaps 0.1 kg a month—once they finish.

Explaining the Quick Rebound

Nutrition scientists suggest the way of the injections is key to understanding the accelerated rebound.

These medications copy a body's own chemical called GLP-1, which helps regulate hunger.

"Artificially providing GLP-1 levels several times higher than the body's typical production may cause the system to produce less of its endogenous hormone, and could reduce responsiveness to its actions," noted Dr. Adam Collins, a nutrition expert.

"Stopping of this GLP-1 'fix' means appetite is uncontrolled, making excessive eating far more likely."

A Chronic Condition?

Health authorities recommend the injections for individuals with obesity-related health risks, alongside prescribed diet and exercise modifications.

A number of clinicians contend that, given the significant potential of weight regain, the therapy might need to be life-long.

This opinion is echoed by pharmaceutical companies, who state that the findings "underscore the long-term character of excess weight," akin to managing diseases like high blood pressure.

User Testimonies

People who have stopped the medication describe a intense resurgence of cravings.

"I experienced a trigger flipping and you become starving," recalled a patient.

This difficulty is compounded if patients have not developed lasting lifestyle or habit changes during therapy.

Significant Adoption

Survey data show that a significant number of people in the UK have tried weight-loss jabs in the last 12 months, with demand remaining high.

• Use is greater among females than males.
• The middle-aged demographic shows the greatest level of interest.
• A large proportion obtain the medications through private prescriptions rather than public health services.

Ultimately, researchers stress that while these medications are potent tools for shedding pounds, they are not a magic solution and maintained weight loss likely depends on ongoing behavioural management.